DoW Joint Warfighter Medical, Military Medical Research and Development Award

The Military Medical Research and Development Award is offered through the Joint Warfighter Medical Research Program, which is managed by the Congressionally Directed Medical Research Programs within the Defense Health Agency Research and Development enterprise. This funding opportunity is part of a broader congressional initiative established in 2012 to accelerate high-priority military medical solutions and address gaps in care for Service Members and Military Health System beneficiaries. The program emphasizes continuation of prior Department of Defense-funded efforts that are near achieving impactful outcomes, rather than supporting early-stage or entirely new research concepts. The primary purpose of this award mechanism is to fund the logical continuation of previously supported research projects that demonstrate strong potential to advance toward clinical application or implementation. Eligible projects must align with at least one of several defined focus areas, including infectious disease prevention, hemorrhage control, temperature-related injuries, musculoskeletal injury treatment, and radiation exposure countermeasures. The program prioritizes late-stage preclinical development, translational research, technology demonstration, and clinical research, with a strong emphasis on readiness for transition into military healthcare settings. Funding is provided under two primary tracks: the standard Military Medical Research and Development Award and a Clinical Research or Clinical Trial Option. The standard award supports advanced development projects, while the clinical option supports observational studies, clinical trials, and related research involving human subjects or data. The total available funding is expected to support a limited number of awards, with capped budgets depending on the selected track. The maximum period of performance for funded projects is three years, and funding must be used within federal fiscal constraints. Eligibility is broad in terms of organizational types, including academic institutions, nonprofit organizations, for-profit entities, and government agencies, both domestic and international. However, applicants must meet a critical requirement: they must have previously received Department of Defense funding relevant to the proposed continuation effort. The program explicitly excludes new project concepts and requires evidence that the proposed work represents a direct continuation of prior funded research, with demonstrated progress and readiness at a defined maturity level. The application process follows a two-step submission structure. Applicants must first submit a preapplication through the Electronic Biomedical Research Application Portal, which includes a structured narrative outlining prior work and proposed continuation. Only selected applicants are invited to submit a full application, which includes detailed project narratives, supporting documentation, abstracts, statements of work, transition plans, and additional compliance materials. Extramural applicants submit full applications through Grants.gov, while intramural applicants use eBRAP. Registration in federal systems such as SAM.gov is required prior to submission. Applications are evaluated through a rigorous two-tier review process consisting of peer review and programmatic review. Key evaluation criteria include research strategy and feasibility, potential impact on military health outcomes, alignment with program priorities, and the strength of the transition plan. Additional considerations include regulatory readiness, statistical analysis plans, personnel expertise, and the ability to successfully recruit and manage study populations where applicable. The timeline for this funding opportunity includes a preapplication deadline in August 2026, followed by invitation notifications in September and full application submission in November. Awards are anticipated to be made by September 2027, with funding tied to fiscal year allocations. Successful applicants must comply with post-award reporting requirements, including annual progress reports and, where applicable, clinical trial registration and reporting obligations.

Focus on demonstrating clear continuation of prior DOD-funded work with strong readiness level and transition potential; align tightly with specified focus areas; emphasize military relevance and impact